World leaders commit to new targets to end TB

World leaders at the UN High-Level Meeting on TB have approved a Political Declaration with ambitious new targets for the next five years to advance the global efforts towards ending the TB epidemic.

Read More →

TB preventive therapy price cut

USAID and PEPFAR announce that they have secured a 30% price reduction on the TB preventive treatment regimen called 3HP, taking the price from $14.25 to $9.99 for a three-month patient course.

Read More →

Open letters to Johnson & Johnson requesting equitable access to bedaquiline

Ukraine, Belarus, Azerbaijan and Moldova demand that Johnson & Johnson take urgent action to improve equitable access to bedaquiline in all countries with a high burden of TB.

Read More →

Nearly all countries “far off track” of meeting TB research targets despite publicly reaffirming commitments at UN

A sobering new analysis from Treatment Action Group shows that governments failed to meet previous commitments to fund TB research.

Read More →

At this week’s UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign calls on political leaders to take urgent action for equitable access to shorter, safer TB regimens

Ahead of the UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign is sounding the alarm that the political declaration commits neither the funding nor the actions needed to expand access to the best-available TB regimens and diagnostics.

Read More →

Reduced price and increased access to Cepheid’s TB test

Global Fund, Stop TB Partnership and USAID announce new collaboration with Danaher to reduce price and increase access to Cepheid’s TB test. Five million additional tests can be procured with this lower price.

Read More →

Global Fund Results Report 2023

Results in the fight against HIV, TB and malaria exceed pre-COVID-19 numbers; yet colliding crises keep the world way off track to achieve 2030 targets.

Read More →

Lancet Commission calls for renewed global response on TB

Without action, more than 27 million lives could be lost between now and 2050.

Read More →

Johnson & Johnson and Cepheid must expand access to TB drug and tests

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools.

Read More →

Unprecedented focus on global public health at UN General Assembly

WHO urges world leaders to commit to progress on pandemic prevention, preparedness and response and to secure health for all, end TB, and reinvigorate SDGs.

Read More →

Page 1 of 126 · Total posts: 10

1 2 Last→